• Home
  • Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.

Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.

Author List
Quintanilha JCF, Wang J, Sibley AB, Xu W, Espin-Garcia O, Jiang C, Etheridge AS, Ratain MJ, Lenz HJ, Bertagnolli M, Kindler HL, Dickler MN, Venook A, Liu G, Owzar K, Lin D, Innocenti F
Publication
International journal of cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/228782838
Publication Year
2021
PubMed ID
34528705
Publication Title
Quintanilha JCF, Wang J, Sibley AB, Xu W, Espin-Garcia O, Jiang C, Etheridge AS, Ratain MJ, Lenz HJ, Bertagnolli M, Kindler HL, Dickler MN, Venook A, Liu G, Owzar K, Lin D, Innocenti F. Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens. Int J Cancer. 2022 01 15; 150(2):279-289.